Latest contributions
TOP-CABG: the timing of platelet inhibition after coronary artery bypass grafting trial
02 Sep 2025
Jonathan Curio provides his take on TOP-CABG, presented by Xin Yuan at ESC Congress 2025 in Madrid.
Author
PCRonline @ ESC Congress 2025: the interventional cardiology perspective!
26 Jul 2025
Stay updated with the latest in interventional cardiology at #ESCCongress 2025!
Valve-in-valve TAVI
21 May 2025 – From EuroPCR 2025
Explore valve-in-valve TAVI strategies for patients with degenerated surgical valves, focusing on small aortic annuli. This session covers the impact of valve design and implant techniques, valve fracturing methods, procedural outcomes of repeat TAVI, and mid-to-long-term results from the ACCURATE NEO 2 study.
Clinical and echocardiographic outcomes among the first 500 patients treated with a dedicated transcatheter aortic valve for pure aortic regurgitation in the Align-AR clinical trial
31 Mar 2025
Jonathan Curio interviews Raj Makkar about the results of the Align-AR trial which he presented during the ACC.25 in Chicago.
Author
Author
PCRonline @ ACC.25 Scientific Sessions
07 Feb 2025
Live updates on a selection of major Late Breaking Clinical Trials of interest in interventional cardiology presented at the American College of Cardiology 2025 Scientific Sessions #ACC25
MitrAI score: machine learning models to predict mortality at 12, 24, 36 and 48 months in patients with primary and secondary MR treated by TEER
31 Aug 2024
Jonathan Curio provides his take on the MitrAI score study which was presented by Luigi Biasco at ESC Congress 2024 in London.
Author
PCRonline @ ESC Congress 2024: the interventional cardiology perspective!
26 Jul 2024
What was new and hot in interventional cardiology at #ESCCongress 2024!
PCR Tricuspid Focus Group - Referral Meeting in Cologne
13 Jun 2024
Join your peers for this meeting on 5 November 2025 in Cologne, Germany!
Applying the TRILUMINATE eligibility criteria to real-world patients receiving tricuspid valve transcatheter edge-to-edge repair
19 Mar 2024
This study, based on the trial inclusion and exclusion criteria, aimed to compare outcomes in a contemporary “real-world” T-TEER cohort stratified by TRILUMINATE eligibility or ineligibility.
Reviewer
Reviewer
TAVI - Alternative access - Part 1
19 Nov 2023 – From PCR London Valves 2023
Learn more about the evolving landscape of TAVI techniques and access options with this session: experience the first-hand application of JenaValve Trilogy via transaxillary access in treating aortic regurgitation, delve into the challenges and solutions of transcaval TAVI in a patient with right iliac vein occlusion,...
Mitral TEER - Part 1
19 Nov 2023 – From PCR London Valves 2023
Consult this session to gain insights into the complexities of Mitral TEER: witness an innovative solution for recurrent mitral regurgitation post-M-TEER showcasing the efficacy of three MitraClips, navigate the challenging terrain of mitral flail repair in a patient with a left main chronic total occlusion, explore...
Short-term outcomes of tricuspid edge-to-edge repair in clinical practice – bRIGHT study
12 Jun 2023
The aim of the b-RIGHT study was to assess the safety and performance of T-TEER using the TriClip (Abbott) in a contemporary, real-world setting...
Reviewer
Reviewer
Reviewer
Coronary obstruction from TAVR in native aortic stenosis : development and validation of multivariate prediction model
30 Mar 2023
This study aimed to develop a multivariable prediction model to estimate the risk of CO after TAVI in native anatomy based on the largest available pre-procedural CT dataset.
Reviewer
Reviewer
Reviewer
Transcatheter edge-to-edge repair of functional mitral regurgitation in heart failure: Final five-year results from the COAPT Trial
06 Mar 2023
Alex Sticchi & Jonathan Curio provide their take on the clinical trial presented by Gregg W. Stone at the American College of Cardiology Scientific Sessions (ACC.23/WCC).
Author
Author
TRILUMINATE pivotal: A landmark randomized clinical trial of transcatheter tricuspid valve edge-to-edge repair for tricuspid regurgitation
04 Mar 2023
Jonathan Curio and Alex Sticchi provide their take on this clinical trial which was presented by Paul Sorajja at the American College of Cardiology Scientific Session (ACC.23/WCC).
Author
Author
PCRonline @ ACC.23/WCC Scientific Sessions
23 Feb 2023
Live updates on a selection of major Late Breaking Clinical Trials of interest in interventional cardiology presented at the American College of Cardiology / World Heart Federation 2023 Scientific Sessions #ACC23 #WCCardio.
Sex-related characteristics and short-term outcomes of patients undergoing transcatheter tricuspid valve intervention for tricuspid regurgitation
26 Dec 2022
Population-based studies show a higher prevalence of significant TR in women and following that in published and ongoing trials on TTVI more women than men were enrolled. However, so far it has not been investigated whether such differences in epidemiology also would affect TTVI outcomes...
Reviewer
Reviewer
PCR London Valves 2022 - summaries of late-breaking science, trials and innovations
02 Dec 2022
Jonathan Curio provides a brief overview of the new data presented at PCR London Valves 2022 in the field of Tricuspid, TAVI and Mitral valves by providing summarised key take-aways!
Author
PCR Live from London: episode 5
29 Nov 2022 – From PCR London Valves 2022
Consult this episode 5 of PCR Live from London to discover a presentation regarding simulation lab sessions, and learn more about the possible complications in TEER and their management.
Rapid-fire abstracts: Session 6
28 Nov 2022 – From PCR London Valves 2022
Consult this session to discover a selection of abstracts presented during PCR LV 2022: hydrodynamic performance of ACURATE neo2 for valve-in-valve across different surgical bioprostheses, impact of leaflets splitting on coronary access after redo TAVI in failed supra-annular platforms, same-day discharge after TF and alternate access...
Valve-in-valve TAVI: session 1
27 Nov 2022 – From PCR London Valves 2022
ViV TAVI in a patient with previous Bentall's operation, ViV for a failed surgical aortic bioprosthesis with a misaligned mitral bioprosthesis, TAVI for severe aortic regurgitation caused by infective endocarditis after homograft surgery, and much more in this PCR LV 2022 session about ViV TAVI!
1-year outcomes of Cardioband Tricuspid Valve Reconstruction System early feasibility study
10 Oct 2022
Reviewer
Reviewer
The PROTECTED TAVR study: Cerebral embolic protection during transcatheter aortic valve replacement
18 Sep 2022
Jonathan Curio provides his take on the PROTECTED TAVR study which was presented by Samir R. Kapadia at TCT 2022. The aim was to evaluate whether TAVR with cerebral embolic protection would reduce the rate of clinical stroke in transfemoral TAVR.
Author
PCRonline @ TCT 2022 - Get the international perspective!
12 Sep 2022
Thanks to the contribution of a team of interventional cardiologists from around the globe, view the international perspective on Late-breaking Clinical Trials and Science released at TCT 2022 - check out the list here!
Structural Heart Disease pre-case planning tutorials: Mitral valve TMVR
08 Sep 2022
In this series of tutorials, Gilbert Tang proposes instruction videos on how to use 3mensio for pre-case planning in Mitral Valve-in-Valve TMVR.
Structural Heart Disease pre-procedural sizing and planning tutorials: TAVR / TAVI
17 Aug 2022
In this series of tutorials, Gilbert Tang proposes instruction videos on how to use 3mensio for pre-procedural sizing and planning in TAVR, Valve-in-Valve, re-do TAVR, alternate access and more.
Leaflet-to-annulus index and residual tricuspid regurgitation following tricuspid transcatheter edge-to-edge repair
21 Jun 2022
As the relationship between leaflet length and annular dimension becomes highly relevant in TR pathophysiology, the present study aimed to evaluate the impact of tricuspid leaflet-to-annulus mismatch on outcomes after T-TEER.
Reviewer
Reviewer
Reviewer
EuroPCR 2022 - summaries of late-breaking science, trials and registries in Valvular Interventions and Structural Heart Disease
22 May 2022
Jonathan Curio provides his take on the new data presented at EuroPCR 2022 in Valvular Interventions and Structural Heart Disease by providing summarised key take-aways!
Author
Transcaval versus transaxillary TAVR in contemporary practice - a propensity-weighted analysis
09 May 2022
As there has been no systematic comparison of transcaval and transaxillary access so far, the present study aimed to compare these two approaches with each other, as well as with transfemoral access.
Reviewer
Reviewer
Cardiohepatic syndrome is associated with poor prognosis in patients undergoing tricuspid transcatheter edge-to-edge valve repair
27 Jan 2022
As the prognostic role of cardiohepatic syndrome (CHS) has not yet been evaluated, Stolz et al. in the present study assessed its impact on T-TEER outcomes.
Reviewer
Reviewer
